1 / 1 DeCS    
Descriptor English:   Hyperlipoproteinemia Type V 
Descriptor Spanish:   Hiperlipoproteinemia Tipo V 
Descriptor Portuguese:   Hiperlipoproteinemia Tipo V 
Synonyms English:   Hyperchylomicronemia Late Onset
Hyperchylomicronemia Late Onsets
Hyperchylomicronemia With Hyperprebetalipoproteinemia, Familial
Hyperchylomicronemia, Late Onset
Hyperchylomicronemia, Late-Onset
Hyperchylomicronemias, Late-Onset
Hyperlipemia, Combined Fat And Carbohydrate Induced
Hyperlipemia, Combined Fat And Carbohydrate-Induced
Hyperlipemia, Mixed
Hyperlipemias, Mixed
Hyperlipidemia, Type V
Hyperlipidemias, Type V
Hyperlipoproteinemia Type 5
Hyperlipoproteinemia Type 5s
Hyperlipoproteinemia, Type V
Hyperlipoproteinemias, Type V
Late-Onset Hyperchylomicronemia
Late-Onset Hyperchylomicronemias
Mixed Hyperlipemia
Mixed Hyperlipemias
Type V Hyperlipidemia
Type V Hyperlipidemias
Type V Hyperlipoproteinemia
Type V Hyperlipoproteinemias  
Tree Number:   C16.320.565.398.493
C18.452.584.500.500.644.495
C18.452.584.500.500.851.750
C18.452.648.398.493
Definition English:   A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma CHYLOMICRONS and TRIGLYCERIDES contained in VERY-LOW-DENSITY LIPOPROTEINS. Type V hyperlipoproteinemia is often associated with DIABETES MELLITUS and is not caused by reduced LIPOPROTEIN LIPASE activity as in HYPERLIPOPROTEINEMIA TYPE I
History Note English:   80 
Allowable Qualifiers English:  
BL blood CF cerebrospinal fluid
CI chemically induced CL classification
CO complications DI diagnosis
DG diagnostic imaging DH diet therapy
DT drug therapy EC economics
EM embryology EN enzymology
EP epidemiology EH ethnology
ET etiology GE genetics
HI history IM immunology
ME metabolism MI microbiology
MO mortality NU nursing
PS parasitology PA pathology
PP physiopathology PC prevention & control
PX psychology RT radiotherapy
RH rehabilitation SU surgery
TH therapy UR urine
VE veterinary VI virology
Record Number:   7135 
Unique Identifier:   D006954 


   DISEASES [C]
      Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
         Genetic Diseases, Inborn [C16.320]
            Metabolism, Inborn Errors [C16.320.565]
               Amino Acid Metabolism, Inborn Errors [C16.320.565.100] +
               Amino Acid Transport Disorders, Inborn [C16.320.565.151] +
               Amyloidosis, Familial [C16.320.565.176] +
               Brain Diseases, Metabolic, Inborn [C16.320.565.189] +
               Carbohydrate Metabolism, Inborn Errors [C16.320.565.202] +
               Cytochrome-c Oxidase Deficiency [C16.320.565.240]
               Hyperbilirubinemia, Hereditary [C16.320.565.300] +
               Lipid Metabolism, Inborn Errors [C16.320.565.398]
                  Barth Syndrome [C16.320.565.398.224]
                  Hyperlipidemia, Familial Combined [C16.320.565.398.450]
                  Hyperlipoproteinemia Type I [C16.320.565.398.465]
                  Hyperlipoproteinemia Type II [C16.320.565.398.481]
                  Hyperlipoproteinemia Type III [C16.320.565.398.483]
                  Hyperlipoproteinemia Type IV [C16.320.565.398.487]
                  Hyperlipoproteinemia Type V [C16.320.565.398.493] 
                  Hypolipoproteinemias [C16.320.565.398.500] +
                  Lipidoses [C16.320.565.398.641] +
                  Lipodystrophy, Congenital Generalized [C16.320.565.398.745]
                  Smith-Lemli-Opitz Syndrome [C16.320.565.398.850]
                  Xanthomatosis, Cerebrotendinous [C16.320.565.398.925]
               Lysosomal Storage Diseases [C16.320.565.595] +
               Metal Metabolism, Inborn Errors [C16.320.565.618] +
               Peroxisomal Disorders [C16.320.565.663] +
               Progeria [C16.320.565.753]
               Purine-Pyrimidine Metabolism, Inborn Errors [C16.320.565.798] +
               Renal Tubular Transport, Inborn Errors [C16.320.565.893]
               Steroid Metabolism, Inborn Errors [C16.320.565.925] +


   DISEASES [C]
      Nutritional and Metabolic Diseases [C18]
         Metabolic Diseases [C18.452]
            Lipid Metabolism Disorders [C18.452.584]
               Dyslipidemias [C18.452.584.500]
                  Hyperlipidemias [C18.452.584.500.500]
                     Hypercholesterolemia [C18.452.584.500.500.396]
                     Hyperlipidemia, Familial Combined [C18.452.584.500.500.438]
                     Hyperlipoproteinemias [C18.452.584.500.500.644]
                        Hyperlipoproteinemia Type I [C18.452.584.500.500.644.237]
                        Hyperlipoproteinemia Type II [C18.452.584.500.500.644.475]
                        Hyperlipoproteinemia Type III [C18.452.584.500.500.644.485]
                        Hyperlipoproteinemia Type IV [C18.452.584.500.500.644.490]
                        Hyperlipoproteinemia Type V [C18.452.584.500.500.644.495] 
                     Hypertriglyceridemia [C18.452.584.500.500.851] +


   DISEASES [C]
      Nutritional and Metabolic Diseases [C18]
         Metabolic Diseases [C18.452]
            Lipid Metabolism Disorders [C18.452.584]
               Dyslipidemias [C18.452.584.500]
                  Hyperlipidemias [C18.452.584.500.500]
                     Hypercholesterolemia [C18.452.584.500.500.396]
                     Hyperlipidemia, Familial Combined [C18.452.584.500.500.438]
                     Hyperlipoproteinemias [C18.452.584.500.500.644] +
                     Hypertriglyceridemia [C18.452.584.500.500.851]
                        Hyperlipoproteinemia Type IV [C18.452.584.500.500.851.500]
                        Hyperlipoproteinemia Type V [C18.452.584.500.500.851.750] 
                        Hypertriglyceridemic Waist [C18.452.584.500.500.851.875]


   DISEASES [C]
      Nutritional and Metabolic Diseases [C18]
         Metabolic Diseases [C18.452]
            Metabolism, Inborn Errors [C18.452.648]
               Amino Acid Metabolism, Inborn Errors [C18.452.648.100] +
               Amino Acid Transport Disorders, Inborn [C18.452.648.151] +
               Amyloidosis, Familial [C18.452.648.176] +
               Brain Diseases, Metabolic, Inborn [C18.452.648.189] +
               Carbohydrate Metabolism, Inborn Errors [C18.452.648.202] +
               Hyperbilirubinemia, Hereditary [C18.452.648.300] +
               Lipid Metabolism, Inborn Errors [C18.452.648.398]
                  Barth Syndrome [C18.452.648.398.224]
                  Hyperlipidemia, Familial Combined [C18.452.648.398.450]
                  Hyperlipoproteinemia Type I [C18.452.648.398.465]
                  Hyperlipoproteinemia Type II [C18.452.648.398.481]
                  Hyperlipoproteinemia Type III [C18.452.648.398.483]
                  Hyperlipoproteinemia Type IV [C18.452.648.398.487]
                  Hyperlipoproteinemia Type V [C18.452.648.398.493] 
                  Hypolipoproteinemias [C18.452.648.398.500] +
                  Lipidoses [C18.452.648.398.641] +
                  Lipodystrophy, Congenital Generalized [C18.452.648.398.745]
                  Smith-Lemli-Opitz Syndrome [C18.452.648.398.850]
                  Xanthomatosis, Cerebrotendinous [C18.452.648.398.925]
               Lysosomal Storage Diseases [C18.452.648.595] +
               Metal Metabolism, Inborn Errors [C18.452.648.618] +
               Peroxisomal Disorders [C18.452.648.663] +
               Progeria [C18.452.648.753]
               Purine-Pyrimidine Metabolism, Inborn Errors [C18.452.648.798] +
               Renal Tubular Transport, Inborn Errors [C18.452.648.893]
               Steroid Metabolism, Inborn Errors [C18.452.648.925] +